Also trades as: IPOT.CN (CNQ) · $vol 0M
ISCNF OTC
Isracann Biosciences Inc.
1W: +900.0%
1M: +900.0%
3M: +0.0%
YTD: +900.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+58.5% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$2M
+58.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
+9.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | -$6M | -$24M | -$25M | -$5M |
| Depreciation & Amort. | $584K | $45K | $45K | $41K | $42K |
| Stock-Based Comp. | $3M | $1M | $1M | $739K | $57K |
| Change in Working Capital | $190K | $72K | $113K | -$63K | $694K |
| Other Non-Cash Items | $438K | $1M | $12M | $20M | $2M |
| Operating Cash Flow | -$3M | -$3M | -$10M | -$4M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$204K | -$509K | -$14K | $0 |
| Acquisitions (Net) | $0 | -$30K | $34K | $285K | $39K |
| Investment Purchases | $0 | $0 | -$2M | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$623K | -$501K | -$138K | -$117K |
| Investing Cash Flow | -$6M | -$857K | -$3M | $134K | -$77K |
| — Financing Activities — | |||||
| Net Debt Issuance | $13M | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $3M | $10M | $13M | $2M | $0 |
| Financing Cash Flow | $17M | $10M | $13M | $2M | $130K |
| Net Change in Cash | $8M | -$4M | -$287K | -$2M | -$2M |
| Cash End of Period | $8M | $4M | $4M | $2M | $214K |
| Free Cash Flow | -$9M | -$3M | -$11M | -$4M | -$2M |